Overview
Charles Medert is an Ophthalmologist in Austin, Texas. Dr. Medert is highly rated in 1 condition, according to our data. His top areas of expertise are Glaucoma, Cataract, Ocular Hypertension (OHT), and Age-Related Macular Degeneration (ARMD). Dr. Medert is currently accepting new patients.
His clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2700 Bee Caves Rd, Austin, TX 78746
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Austin Retina Associates PLLC
Philip Storey is an Ophthalmologist in Austin, Texas. Dr. Storey is highly rated in 11 conditions, according to our data. His top areas of expertise are Endophthalmitis, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Vitrectomy, and Cataract Removal. Dr. Storey is currently accepting new patients.
Austin Retina Associates PLLC
Robert Wong is an Ophthalmologist in Austin, Texas. Dr. Wong is highly rated in 14 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Vitrectomy, and Cataract Removal. Dr. Wong is currently accepting new patients.
Austin Retina Associates PLLC
Peter Nixon is an Ophthalmologist in Austin, Texas. Dr. Nixon is highly rated in 19 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Artery Occlusion, and Vitrectomy. Dr. Nixon is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- GlaucomaDr. Medert isAdvanced. Learn about Glaucoma.
- Experienced
- Age-Related Macular Degeneration (ARMD)Dr. Medert isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- CataractDr. Medert isExperienced. Learn about Cataract.
- Diabetic RetinopathyDr. Medert isExperienced. Learn about Diabetic Retinopathy.
- HyphemaDr. Medert isExperienced. Learn about Hyphema.
- Increased Intracranial PressureDr. Medert isExperienced. Learn about Increased Intracranial Pressure.
- Late-Onset Retinal DegenerationDr. Medert isExperienced. Learn about Late-Onset Retinal Degeneration.